Prophylactic Anticoagulation for Catheter-related Thrombosis
Status:
Recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
The main objective of this study is to compare the efficacy and safety of aspirin, low
molecule heparin and rivaroxaban for preventing catheter-related thrombosis in
middle-to-high-risk ambulatory patients with cancer and implantable venous access ports.
Phase:
Phase 4
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University